Navigation Links
Budesonide Market (Global, China) 2019 - 2020 Forecasts in 2015 Research Reports
Date:10/29/2015

PUNE, India, October 29, 2015 /PRNewswire/ --

ReportsnReports.com adds "Investigation Report on China Budesonide Market, 2010-2019" and "Global and Chinese Budesonide (CAS 51333-22-3) Industry, 2015 Market Research Report" with 2019 and 2020 forecasts data and information to its online business intelligence library.

Complete report on China budesonide market spread across 30 pages, profiling 5 companies and supported with 19 charts is now available at http://www.reportsnreports.com/reports/402267-investigation-report-on-china-budesonide-market-2010-2019.html .

With the climatic and environmental changes, seasonal asthma has become the main reason for respiratory ailments. According to an epidemiological survey, the incidence of respiratory ailments is 16% of the incidence of all diseases. About 280 million people in the world suffer from different degrees of seasonal asthma, more so in industrialized countries and regions where tobacco consumption is high. 5% of adults and 20% of children there have been attacked by this disease and many of them come down with bronchial asthma induced by chronic cough.

Nearly 300 million people in China contract respiratory ailments, among which over 50 million suffer from cough with an annual growth rate of 4% and 15Budesonide20 million asthma. Budesonide, an adrenocortical hormone, was developed by Astrazeneca in the 1990s. It is mainly used for the treatment of non-Budesonide glucocorticoid dependent or glucocorticoid Budesonide dependent bronchial asthma and chronic obstructive pulmonary disease (COPD). In Jun. 1997, Budesonide aerosol got FDA's approval. In recent years, with the steady growth of global demand, Budesonide has occupied an important position in the TOP10 respiratory drugs.

In 1994, China approved the import of Budesonide for clinical purposes. After being marketed by Astra (Wuxi) in China in 1995, Budesonide develops fast with annual sales rising from CNY 60 million in 2005 to CNY 595 million in 2014 and CAGR reaching up to 29% during the period of 2005Budesonide2014. Budesonide enjoys a vast demand in China. Currently, Budesonide in the Chinese market mainly come from the following companies: Lunan Better Pharmaceutical Co., Ltd, Orion Corporation (Finland), WELLCOME AUSTRALIA LTD.(AU), SYNMOSA BIOPHARMA CORPORATION (TW) and Astra AB (Sweden). While they all take up certain shares in the market, WELLCOME AUSTRALIA LTD. (AU) has the largest market share of 88% with sales value reaching up to CNY 524 million in 2014. Order a copy of this report at http://www.reportsnreports.com/purchase.aspx?name=402267 .

The market size of Budesonide in China is expected to keep growing in the next few years. Readers of this report can get information on Budesonide market size of China, Budesonide market share of manufacturers in China, price of Budesonide in Chinese market, major manufacturers of Budesonide in Chinese market and overall Budesonide market outlook in China. Budesonide manufacturers of cortin drugs as well as investors/ research institutions interested in Chinese medicine market are suggested to buy a copy of this report.

Explore other new reports on Pharmaceuticals at http://www.reportsnreports.com/market-research/pharmaceuticals/ .

Another research titled Global and Chinese Budesonide (CAS 51333-22-3) Industry, 2015 Market Research Report is a professional and in-depth study on the current state of the global Budesonide industry with a focus on the Chinese market. The report provides key statistics on the market status of the Budesonide manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.

Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2010-2015 market shares for each company. Through the statistical analysis, the report depicts the global and Chinese total market of Budesonide industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export. The total market is further divided by company, by country, and by application/type for the competitive landscape analysis. The report then estimates 2015-2020 market development trends of Budesonide industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out. In the end, the report makes some important proposals for a new project of Budesonide Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2020 global and Chinese Budesonide industry covering all important parameters. Comprehensive table of contents and more on this report is available at http://www.reportsnreports.com/reports/414316-global-and-chinese-budesonide-cas-51333-22-3-industry-2015-market-research-report.html .

About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Connect With Us on:  

Facebook: https://www.facebook.com/pages/ReportsnReports/191441427571689

LinkedIn: http://www.linkedin.com/company/reportsnreports

Twitter: https://twitter.com/marketsreports

G+ / Google Plus: https://plus.google.com/111656568937629536321/posts

Pinterest: http://www.pinterest.com/comeonseo/reportsnreports/

RSS/Feeds: http://www.reportsnreports.com/feed/l-latestreports.xml


Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com



'/>"/>
SOURCE ReportsnReports
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Meritage Pharma Announces Positive Results of Oral Budesonide Suspension for Treatment of Eosinophilic Esophagitis in Adolescent and Adult Patients
2. Paragon Bioservices Hires Kevin Sly as SVP Marketing & Commercial Strategy
3. Emerging Opportunities in the Spanish Enteric Diseases Diagnostic Testing Market 2016 - Reviews Features and Operating Characteristics of Major Analyzers used for Microbiology Testing
4. Emerging Opportunities in the UK Enteric Diseases Diagnostic Testing Market 2016 - Reviews Features and Operating Characteristics of Major AnalyzersUsed for Microbiology Testing
5. Pharmaceutical Logistics Market in North America 2015-2019 - Reportlinker Review
6. Emerging Strategies for the Spanish Hospital Tumor Marker Testing Market 2016 - Current Instrumentation Technologies and Feature Comparison of Leading Analyzers
7. Emerging Strategies for the Japanese Hospital Hemostasis Diagnostics Market 2016 - Volume and Sales forecasts for 40 Coagulation Procedures Performed in Japanese Hospitals
8. Emerging Strategies for the Spanish Hospital Hemostasis Diagnostics Market 2016 - Reagent and Instrument Sales Forecasts
9. Emerging Opportunities in the US Enteric Diseases Diagnostic Testing Market 2016 - Profiles Key Suppliers and Potential Market Entrants Developing Innovative Technologies and Products
10. Global Bio Pharma Logistics Market 2015-2019 - Increase in Outsourcing of Bio Pharmaceutical Labeling and Packaging
11. Emerging Opportunities in the Malaria Diagnostic Testing Market 2016 - Profiles Leading Suppliers and Recent Market Entrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/14/2019)... ... 15, 2019 , ... Author Madeline A. Garner shares her own experience with ... and provides survivors with information about their experiences and resources they can use. , ... a psychotherapist for 36 years and as an energy healer for eight years. She ...
(Date:8/14/2019)... ... August 13, 2019 , ... Last week during the NCPDP ... of the NCPDP Real-Time Prescription Benefit (RTPB) Standard. The vote to approve the ... Standard from across the industry, with representation from all industry stakeholder groups, including ...
(Date:8/12/2019)... ... August 12, 2019 , ... The National Association of ... Power Tools , which explores how technology and innovation partners can increase the ... Director of Program Relations, the series dives deep with vetted, private-industry companies — ...
Breaking Medicine Technology:
(Date:8/14/2019)... ... August 14, 2019 , ... Teguar Corporation has claimed the #3719 position ... has long-been established as a mark of success for some of Americas top companies ... made the list in 2015, 2016 and 2017. This year, Teguar secured a spot ...
(Date:8/14/2019)... ... August 15, 2019 , ... ... clinic in Tijuana Mexico. R3 Stem Cell International is offering regenerative procedures with ... Mexico. , A full procedure costs only $2950, which includes a complete IV ...
(Date:8/14/2019)... ... August 13, 2019 , ... In a recent Trivedi Effect ... doubt in your belief systems. , “Doubt can obliterate your old beliefs,” said Master ... to examining them to expand your understanding and your awareness. Trust that the Divine ...
(Date:8/14/2019)... ... 14, 2019 , ... Today, consumers are taking a harder look at what ... body, emotions and energy levels. The trick is finding food and beverages that are ... why founder Chris Harper created Chase – a delicious, guilt free cocktail ...
(Date:8/12/2019)... ... 2019 , ... Parents craving a nutritious and delicious snack for their kids ... feed children in need. IsaKids® Super Smoothie is one of three products launched yesterday ... health and wellness company also debuted Organic Greens, an updated version of its Isagenix ...
Breaking Medicine News(10 mins):